Evidence map›Paper›PMID 39624964›Full record

ArticleAnnals of medicine2024

Haemoglobin levels are associated with echocardiographic measures in a Finnish midlife population.

Joona Tapio, Tommi Grönlund, Kari Kaikkonen, M Juhani Junttila, Mikko P Tulppo, Peppi Koivunen

Abstract read
In one paragraph

Article in Annals of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joona TapioBiocenter Oulu and Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland.
Tommi GrönlundResearch Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
Kari KaikkonenResearch Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
M Juhani JunttilaResearch Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
Mikko P TulppoResearch Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
Peppi KoivunenBiocenter Oulu and Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, Oulu, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWithin normal variation, higher haemoglobin (Hb) levels are associated with unhealthier body composition, adverse metabolism and cardiovascular disease (CVD)-related mortality. Global longitudinal strain (GLS) is a direct, well validated and reproducible echocardiographic measure for the evaluation of cardiac contractile function, providing additional prognostic value for prediction of a variety of cardiac events. This study investigated the relation between Hb levels and cardiac function measures, including GLS, in a Finnish midlife population. MATERIALS AND

methodsEchocardiography was carried out in a subpopulation of the Northern Finland Birth Cohort 1966 at age of 46 (

resultsThe highest Hb tertile had adverse anthropometric and metabolic parameters compared to other Hb tertiles. Of the studied echocardiographic parameters, the highest Hb tertile had the highest left ventricular mass (LVM,

conclusionsHigher Hb levels are associated with an adverse metabolic and inflammatory profile and more adverse cardiac function measures, including GLS, in both sexes in midlife.

Indexed as

EchocardiographyHemoglobinsCardiovascular DiseasesFemaleFinlandHeart VentriclesHumansMaleMiddle AgedHemoglobinsCardiovascular diseaseechocardiographyglobal longitudinal strainhaemoglobin

Identifiers

PMID39624964
PMCPMC11616746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.